FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2884581036> ?p ?o ?g. }

• W2884581036 endingPage "e020723" @default.
• W2884581036 startingPage "e020723" @default.
• W2884581036 abstract "Introduction Methamphetamine dependence is a growing public health concern. There is currently no pharmacotherapy approved for methamphetamine dependence. Lisdexamfetamine (LDX) dimesylate, used in the treatment of attention-deficit hyperactivity disorder and binge eating disorder, has potential as an agonist therapy for methamphetamine dependence, and possible benefits of reduced risk of aberrant use due to its novel formulation. Methods and analysis A double-blind randomised controlled trial will be used to evaluate the efficacy of LDX in reducing methamphetamine use. The target sample is 180 participants with methamphetamine dependence of ≥2 years, using ≥14 days out of the previous 28, who have previously attempted but not responded to treatment for methamphetamine use. Participants will be randomly assigned to receive either a 15-week intervention consisting of induction (1 week of 150 mg LDX or placebo), maintenance (12 weeks of 250 mg LDX or placebo) and reduction (1 week of 150 mg LDX or placebo and 1 week of 50 mg LDX or placebo). All participants will be given access to four sessions of cognitive–behavioural therapy as treatment as usual and receive a 4-week follow-up appointment. The primary outcomes are efficacy (change from baseline in days of methamphetamine use by self-report for the last 28 days at week 13 and urinalyses confirmation of methamphetamine use) and safety (treatment-related adverse events). Secondary outcomes are total number of days of self-report methamphetamine use over the 12-week active treatment, longest period of abstinence during treatment period, percentage of achieving ≥21 days abstinence, craving, withdrawal, dependence, retention, bloodborne virus transmission risk behaviour, criminal behaviour, as well measures of abuse liability, physical and mental health, other substance use, cognitive performance, psychosocial functioning, treatment retention and satisfaction. Additionally, the study will assess the cost-effectiveness of LDX relative to the placebo control. Ethics and dissemination The study has been approved by the Human Research Ethics Committee of St. Vincent’s Hospital, Sydney, Australia (HREC/16/SVH/222). Contact the corresponding author for the full trial protocol. Trial registration number ACTRN12617000657325; Pre-results." @default.
• W2884581036 created "2018-08-03" @default.
• W2884581036 creator A5000117403 @default.
• W2884581036 creator A5003229688 @default.
• W2884581036 creator A5008990660 @default.
• W2884581036 creator A5009894617 @default.
• W2884581036 creator A5010104290 @default.
• W2884581036 creator A5017402556 @default.
• W2884581036 creator A5021706269 @default.
• W2884581036 creator A5027062336 @default.
• W2884581036 creator A5028911674 @default.
• W2884581036 creator A5032460662 @default.
• W2884581036 creator A5034304108 @default.
• W2884581036 creator A5049231118 @default.
• W2884581036 creator A5057715091 @default.
• W2884581036 creator A5074256223 @default.
• W2884581036 creator A5076740440 @default.
• W2884581036 date "2018-07-01" @default.
• W2884581036 modified "2023-10-11" @default.
• W2884581036 title "LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence" @default.
• W2884581036 cites W1070976522 @default.
• W2884581036 cites W1510604256 @default.
• W2884581036 cites W1542076320 @default.
• W2884581036 cites W1972376853 @default.
• W2884581036 cites W1973478969 @default.
• W2884581036 cites W1974432571 @default.
• W2884581036 cites W1974896478 @default.
• W2884581036 cites W1983182638 @default.
• W2884581036 cites W1983682359 @default.
• W2884581036 cites W1984107995 @default.
• W2884581036 cites W1985482629 @default.
• W2884581036 cites W1989556708 @default.
• W2884581036 cites W1990166011 @default.
• W2884581036 cites W2000555003 @default.
• W2884581036 cites W2003497549 @default.
• W2884581036 cites W2012950683 @default.
• W2884581036 cites W2018820143 @default.
• W2884581036 cites W2020457020 @default.
• W2884581036 cites W2020680049 @default.
• W2884581036 cites W2020844317 @default.
• W2884581036 cites W2022056804 @default.
• W2884581036 cites W2028857574 @default.
• W2884581036 cites W2032877010 @default.
• W2884581036 cites W2040276248 @default.
• W2884581036 cites W2049014891 @default.
• W2884581036 cites W2058317558 @default.
• W2884581036 cites W2072839634 @default.
• W2884581036 cites W2073155558 @default.
• W2884581036 cites W2073171215 @default.
• W2884581036 cites W2082850379 @default.
• W2884581036 cites W2086325363 @default.
• W2884581036 cites W2093274439 @default.
• W2884581036 cites W2100835521 @default.
• W2884581036 cites W2106369261 @default.
• W2884581036 cites W2109987251 @default.
• W2884581036 cites W2114496529 @default.
• W2884581036 cites W2115594830 @default.
• W2884581036 cites W2116964671 @default.
• W2884581036 cites W2118662924 @default.
• W2884581036 cites W2120912266 @default.
• W2884581036 cites W2131655181 @default.
• W2884581036 cites W2142522687 @default.
• W2884581036 cites W2144317224 @default.
• W2884581036 cites W2145470773 @default.
• W2884581036 cites W2147186992 @default.
• W2884581036 cites W2148083007 @default.
• W2884581036 cites W2161516646 @default.
• W2884581036 cites W2165758561 @default.
• W2884581036 cites W2167271066 @default.
• W2884581036 cites W2290386279 @default.
• W2884581036 cites W2313191740 @default.
• W2884581036 cites W2316878322 @default.
• W2884581036 cites W2396755452 @default.
• W2884581036 cites W2412299009 @default.
• W2884581036 cites W2558130365 @default.
• W2884581036 cites W2574775094 @default.
• W2884581036 cites W3202425 @default.
• W2884581036 cites W4235985820 @default.
• W2884581036 cites W4240482213 @default.
• W2884581036 cites W1971533312 @default.
• W2884581036 doi "https://doi.org/10.1136/bmjopen-2017-020723" @default.
• W2884581036 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6059315" @default.
• W2884581036 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30030312" @default.
• W2884581036 hasPublicationYear "2018" @default.
• W2884581036 type Work @default.
• W2884581036 sameAs 2884581036 @default.
• W2884581036 citedByCount "10" @default.
• W2884581036 countsByYear W28845810362018 @default.
• W2884581036 countsByYear W28845810362019 @default.
• W2884581036 countsByYear W28845810362020 @default.
• W2884581036 countsByYear W28845810362021 @default.
• W2884581036 countsByYear W28845810362022 @default.
• W2884581036 countsByYear W28845810362023 @default.
• W2884581036 crossrefType "journal-article" @default.
• W2884581036 hasAuthorship W2884581036A5000117403 @default.
• W2884581036 hasAuthorship W2884581036A5003229688 @default.
• W2884581036 hasAuthorship W2884581036A5008990660 @default.
• W2884581036 hasAuthorship W2884581036A5009894617 @default.

• next